Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc C.IPOT

Alternate Symbol(s):  ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


CSE:IPOT - Post by User

Post by maysilverstoneon Jun 16, 2021 5:17pm
167 Views
Post# 33399390

IPOT- Israeli cannabis company to watch

IPOT- Israeli cannabis company to watch
$IPOT, Israel's first pure-play cannabis firm focused on offering low-cost production targeting undersupplied, major European marketplaces, is looking cheap today at $0.23 with a small mc of only $33.35M.
 
Israel has optimal climatic conditions to grow medical cannabis due to the humidity, temperature, and sun exposure. These conditions allow for low production costs estimated at about 1/3 the cost of growing in colder climates like Canada/Europe. Also, Israel is among the highest cannabis use per capita in the world at over 27% with 10k patients on waitlist for medical cannabis due to supply constraints.
 
Isracann has a joint venture agreement in place with a built 55,000 sq ft farm that is expandable to 160,000 sq ft in the near term with access to over 2,000,000 sq ft of private land. With all requisite construction and infrastructural installations completed, they are just waiting on an inspection of the facility.
 
Since Israel has a new leader who's pro MJ and will be legalizing it soon, $IPOT is a great pick to make bank on the new laws.

<< Previous
Bullboard Posts
Next >>